Genecode
@genecode.com
Defeating neurodegenerative diseases by developing systemically, available, safe and effective medicines, building on a deep understanding of neurodegeneration and regeneration of the nervous system.
Genecode's Company Logos
Genecode's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#3FA8FF
Dodger Blue
63, 168, 255
207, 100, 62
75, 34, 0, 0
#A1C5E5
Regent St Blue
161, 197, 229
208, 57, 76
30, 14, 0, 10
#182030
Mirage
24, 32, 48
220, 33, 14
50, 33, 0, 81
About Genecode
GENECODE is a private Estonian-American-Finnish-Dutch R&D company leading the way in developing cutting-edge treatment strategies in neurodegenerative diseases and anti-virals. Founded in Tallinn, Estonia in 1993, GeneCode focuses on pioneering drug design technologies for neurodegenerative diseases like Parkinson's, Alzheimer's, and multiple sclerosis. They strive to create novel small-molecule drug candidates that address the root causes of these debilitating conditions rather than just treating symptoms.
In the realm of anti-viral treatments, GeneCode's innovative approach disrupts viral lifecycles using antisense mechanisms, offering hope for conditions like Hepatitis C, HIV, and Chikungunya virus. With a strong focus on disease modification and cure rather than mere symptom management, GeneCode's patented technologies and collaborations with renowned scientists position them at the forefront of pharmaceutical innovation. Partner with GeneCode for transformative solutions in the fight against neurodegenerative diseases and viral infections
Company type
Privately Held
Year founded
1998
Company size
2-10 employees
